drugset / Trial / NCT04942002

Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial

NCT04942002

Phase 2/3 Unknown 50 enrolled Asociación para Evitar la Ceguera en México
RandomizedParallel-groupDouble-blindTreatment

Summary

A double-blind prospective randomized clinical trial of treatment for optic neuritis comparing visual outcome of patients treated by standard therapy (intravenous methylprednisolone) + placebo injection and standard therapy + retrobulbar methylprednisolone.

Timeline

Start
2021-06-15
Primary completion
2023-06-15
Completion
2023-09-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 2 ml Other
Subject Methylprednisolone Other / unclassified 40 mg/ml Other

Indications